Cargando…
Omega-3 fatty acid-rich fish oil supplementation prevents rosiglitazone-induced osteopenia in aging C57BL/6 mice and in vitro studies
Rosiglitazone is an effective insulin-sensitizer, however associated with bone loss mainly due to increased bone resorption and bone marrow adiposity. We investigated the effect of the co-administration of fish oil rich in omega-3 fatty acids (FAs) on rosiglitazone-induced bone loss in C57BL/6 mice...
Autores principales: | Cugno, Chiara, Kizhakayil, Dhanya, Calzone, Rita, Rahman, Shaikh Mizanoor, Halade, Ganesh V., Rahman, Md M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121944/ https://www.ncbi.nlm.nih.gov/pubmed/33990655 http://dx.doi.org/10.1038/s41598-021-89827-8 |
Ejemplares similares
-
Bone Benefits of Fish Oil Supplementation Depend on its EPA and DHA Content
por: Abou-Saleh, Haissam, et al.
Publicado: (2019) -
Combination of vildagliptin and rosiglitazone ameliorates nonalcoholic fatty liver disease in C57BL/6 mice
por: Mookkan, Jeyamurugan, et al.
Publicado: (2014) -
Effects of Omega-3-Rich Pork Lard on Serum Lipid Profile and Gut Microbiome in C57BL/6NJ Mice
por: Koontanatechanon, Anantawat, et al.
Publicado: (2022) -
Production and Refinement of Omega-3 Rich Oils from Processing By-Products of Farmed Fish Species
por: Šimat, Vida, et al.
Publicado: (2019) -
Development and Sensory Evaluation of Omega-3-Rich Nile Perch Fish Oil-Fortified Yogurt
por: Murage, Margaret W., et al.
Publicado: (2021)